Williams; Theresa M.
Patent Applications and Registrations
Patent applications and USPTO patent grants for Williams; Theresa M..The latest application filed is for "compounds that interact with the ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic ".
Company Profile
11.44.34
Trademarks
- Williams; Theresa M. - Harleysville PA
- Williams; Theresa M. - Harelysville PA
- Williams; Theresa M. - Rahway NJ
- Williams; Theresa M. - Lansdale PA
Trademarks
Patent Activity
| Patent | Date |
|---|---|
| Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease Grant 11,213,515 - Hadari , et al. January 4, 2 | 2022-01-04 |
| Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease Grant 11,026,930 - Hadari , et al. June 8, 2 | 2021-06-08 |
| Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease Grant 11,000,515 - Hadari , et al. May 11, 2 | 2021-05-11 |
| Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease Grant 10,940,139 - Hadari , et al. March 9, 2 | 2021-03-09 |
| Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease Grant 10,933,054 - Hadari , et al. March 2, 2 | 2021-03-02 |
| Compounds for the treatment of cancer and inflammatory disease Grant 10,870,657 - Hadari , et al. December 22, 2 | 2020-12-22 |
| Compounds That Interact With The Ras Superfamily For The Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic App 20200121660 - Hadari; Yaron R. ; et al. | 2020-04-23 |
| Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease Grant 10,588,894 - Hadari , et al. | 2020-03-17 |
| Compounds That Interact With The Ras Superfamily For The Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic App 20200061037 - Hadari; Yaron R. ; et al. | 2020-02-27 |
| Compounds That Interact With The Ras Superfamily For The Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic App 20200054614 - Hadari; Yaron R. ; et al. | 2020-02-20 |
| Compounds For The Treatment Of Cancer And Inflammtory Disease App 20190218229 - Hadari; Yaron R. ; et al. | 2019-07-18 |
| Compounds for the treatment of cancer and inflammatory disease Grant 10,221,191 - Hadari , et al. | 2019-03-05 |
| Compounds That Interact With The Ras Superfamily For The Treatment Of Cancers, Inflammatory Diseases, Rasopathies, And Fibrotic Disease App 20190022074 - HADARI; Yaron R. ; et al. | 2019-01-24 |
| Compounds For The Treatment Of Cancer And Inflammatory Disease App 20170174699 - Hadari; Yaron R. ; et al. | 2017-06-22 |
| Isotopically Labeled Biaryl Urea Compounds App 20150336948 - Altman; Michael D. ; et al. | 2015-11-26 |
| Tricyclic Mglur5 Receptor Modulators App 20130210804 - Anthony; Neville J. ; et al. | 2013-08-15 |
| CGRP receptor antagonists Grant 8,039,460 - Burgey , et al. October 18, 2 | 2011-10-18 |
| Heterocyclic benzodiazepine CGRP receptor antagonists Grant 7,947,678 - Williams May 24, 2 | 2011-05-24 |
| Non-Nucleoside Reverse Transcriptase Inhibitors App 20100168097 - Wolkenberg; Scott E. ; et al. | 2010-07-01 |
| Non-nucleoside Reverse Transcriptase Inhibitors App 20100113421 - Williams; Theresa M. ; et al. | 2010-05-06 |
| Cgrp Receptor Antagonists App 20100113419 - Burgey; Christopher S. ; et al. | 2010-05-06 |
| CGRP receptor antagonists Grant 7,659,264 - Burgey , et al. February 9, 2 | 2010-02-09 |
| CGRP receptor antagonists Grant 7,632,832 - Burgey , et al. December 15, 2 | 2009-12-15 |
| Non-Nucleoside Reverse Transcriptase Inhibitors App 20090131494 - Williams; Theresa M. ; et al. | 2009-05-21 |
| CGRP receptor antagonists Grant 7,534,784 - Burgey , et al. May 19, 2 | 2009-05-19 |
| Heterocyclic benzodiazepine cgrp receptor antagonists App 20090105228 - Williams; Theresa M. | 2009-04-23 |
| CGRP receptor antagonists Grant 7,491,713 - Burgey , et al. February 17, 2 | 2009-02-17 |
| Benzodiazepine CGRP receptor antagonists Grant 7,476,665 - Burgey , et al. January 13, 2 | 2009-01-13 |
| CGRP receptor antagonists Grant 7,452,903 - Burgey , et al. November 18, 2 | 2008-11-18 |
| CGRP receptor antagonists App 20080280857 - Burgey; Christopher S. ; et al. | 2008-11-13 |
| Carboxamide spirolactam CGRP receptor antagonists Grant 7,390,798 - Williams , et al. June 24, 2 | 2008-06-24 |
| Cgrp Receptor Antagonists App 20080125413 - Burgey; Christopher S. ; et al. | 2008-05-29 |
| Cgrp Receptor Antagonists App 20080113966 - Burgey; Christopher S. ; et al. | 2008-05-15 |
| Cgrp Receptor Antagonists App 20080070899 - Burgey; Christopher S. ; et al. | 2008-03-20 |
| Carboxamide Spirolactam Cgrp Receptor Antagonists App 20070293470 - Williams; Theresa M. ; et al. | 2007-12-20 |
| Cgrp Receptor Antagonists App 20070287696 - Burgey; Christopher S. ; et al. | 2007-12-13 |
| CGRP receptor antagonists App 20070225272 - Burgey; Christopher S. ; et al. | 2007-09-27 |
| Tyrosine kinase inhibitors App 20070173525 - Kim; Annette ; et al. | 2007-07-26 |
| CGRP receptor antagonists Grant 7,235,545 - Burgey , et al. June 26, 2 | 2007-06-26 |
| CGRP receptor antagonists Grant 7,205,292 - Burgey , et al. April 17, 2 | 2007-04-17 |
| Benodiazepine spirohydantoin CGRP receptor antagonists Grant 7,205,293 - Bell , et al. April 17, 2 | 2007-04-17 |
| Benzodiazepine CGRP receptor antagonists Grant 7,196,079 - Burgey , et al. March 27, 2 | 2007-03-27 |
| Monocyclic anilide spirohydantoin CGRP receptor antagonists Grant 7,192,954 - Bell , et al. March 20, 2 | 2007-03-20 |
| Cgrp receptor antagonists App 20060194783 - Burgey; Christopher S. ; et al. | 2006-08-31 |
| Benodiazepine spirohydantoin cgrp receptor antagonists App 20060189600 - Bell; Ian M. ; et al. | 2006-08-24 |
| Benzodiazepine cgrp receptor antagonists App 20060148790 - Burgey; Christopher S. ; et al. | 2006-07-06 |
| Monocyclic anilide spirohydantoin cgrp receptor antagonists App 20060148779 - Bell; Ian M. ; et al. | 2006-07-06 |
| CGRP receptor antagonists App 20050256098 - Burgey, Christopher S. ; et al. | 2005-11-17 |
| Tyrosine kinase inhibitors App 20050239815 - Kim, Annette J ; et al. | 2005-10-27 |
| CGRP receptor antagonists Grant 6,953,790 - Burgey , et al. October 11, 2 | 2005-10-11 |
| CGRP receptor antagonists App 20040229861 - Burgey, Christopher S. ; et al. | 2004-11-18 |
| Inhibitors of prenyl-protein transferase App 20040110764 - Stump, Craig A. ; et al. | 2004-06-10 |
| Inhibitors of prenyl-protein transferase Grant 6,610,722 - Stump , et al. August 26, 2 | 2003-08-26 |
| Inhibitors of prenyl-protein transferase Grant 6,562,823 - Dinsmore , et al. May 13, 2 | 2003-05-13 |
| Inhibitors of prenyl-protein transferase Grant 6,534,506 - Nguyen , et al. March 18, 2 | 2003-03-18 |
| Inhibitors of prenyl-protein transferase App 20020123497 - Nguyen, Diem N. ; et al. | 2002-09-05 |
| Inhibitors of prenyl-protein transferase App 20020068747 - Stump, Craig A. ; et al. | 2002-06-06 |
| Inhibitors of prenyl-protein transferase Grant 6,380,228 - Stump , et al. April 30, 2 | 2002-04-30 |
| Inhibitors Of Prenyl-protein Transferase App 20020045759 - Stump, Craig A. ; et al. | 2002-04-18 |
| Inhibitors of prenyl-protein transferase App 20020022633 - Williams, Theresa M. ; et al. | 2002-02-21 |
| Inhibitors of farnesyl-protein transferase Grant 6,248,756 - Anthony , et al. June 19, 2 | 2001-06-19 |
| Biaryl substituted imidazole compounds useful as farnesyl-protein transferase inhibitors Grant 6,080,870 - Anthony , et al. June 27, 2 | 2000-06-27 |
| Inhibitors of farnesyl-protein transferase Grant 6,001,835 - Dinsmore , et al. December 14, 1 | 1999-12-14 |
| Inhibitors of farnesyl-protein transferase Grant 5,977,134 - Ciccarone , et al. November 2, 1 | 1999-11-02 |
| Inhibitors of farnesyl-protein transferase Grant 5,965,578 - Graham , et al. October 12, 1 | 1999-10-12 |
| Inhibitors of farnesyl-protein transferase Grant 5,919,785 - Dinsmore , et al. July 6, 1 | 1999-07-06 |
| Inhibitors of farnesyl-protein transferase Grant 5,859,012 - Dinsmore , et al. January 12, 1 | 1999-01-12 |
| Inhibitors of farnesyl-protein transferase Grant 5,856,326 - Anthony , et al. January 5, 1 | 1999-01-05 |
| Inhibitors of farnesyl-protein transferase Grant 5,780,492 - Dinsmore , et al. July 14, 1 | 1998-07-14 |
| Inhibitors of farnesyl-protein transferase Grant 5,756,528 - Anthony , et al. May 26, 1 | 1998-05-26 |
| Inhibitors of farnesyl-protein transferase Grant 5,736,539 - Graham , et al. April 7, 1 | 1998-04-07 |
| Bisphenyl inhibitors of farnesyl-protein transferase Grant 5,710,171 - Dinsmore , et al. January 20, 1 | 1998-01-20 |
| Inhibitors of farnesyl-protein transferase Grant 5,631,280 - Ciccarone , et al. May 20, 1 | 1997-05-20 |
| Benzamide-containing inhibitors of farnesyl-protein transferase Grant 5,578,629 - Ciccarone , et al. November 26, 1 | 1996-11-26 |
| Prodrugs of inhibitors of farnesyl-protein transferase Grant 5,534,537 - Ciccarone , et al. July 9, 1 | 1996-07-09 |
| Peptides having atrial natriuretic factor activity Grant 5,204,328 - Nutt , et al. April 20, 1 | 1993-04-20 |
| Peptides having ANF activity Grant 5,057,603 - Nutt , et al. October 15, 1 | 1991-10-15 |
Company Registrations
| NCAGE Code | SB593 | WILLIAMS THERESA M. |
| NCAGE Code | 4NNG9 | WILLIAMS THERESA M |
| CAGE Code | SB593 | WILLIAMS THERESA M. |
| CAGE Code | 4NNG9 | WILLIAMS THERESA M |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 